Article

Hhamodia.com on 2022-01-28 10:38

EU Drug Regulator OKs Pfizer COVID Pill for High-Risk Patients

The European Union's drug regulator on Thursday gave the green light to Pfizer Inc.'s antiviral COVID-19 pill for treating adults at risk of severe

Related news

EU regulator OKs Pfizer vaccine booster for 18 and older The Wichita Eagle
United States , Netherlands , Amsterdam
Pfizer says its COVID pill doesn’t work for healthier patients LA Times
San Francisco Bay Area , Infectious Diseases
EU regulator OKs Pfizer vaccine booster for 18 and older - Mon, 04 Oct 2021 PST The Spokesman-Review
United States , Netherlands , Amsterdam
EU regulator OKs Pfizer vaccine booster journalrecord.com
Oklahoma City
Pfizer says antiviral pill cuts risk of severe COVID-19 by nearly 90 per cent Sydney Morning Herald
United Kingdom
Pfizer says its experimental pill reduces risk of hospitalization, death from COVID-19 CNN
BCovid: Pfizer says antiviral pill 89% effective in high risk cases bbc.co.uk
Pfizer antiviral pill reduced risk of COVID hospitalization, death by 89% in high-risk people, study shows pressherald.com
United States , United Kingdom , Massachusetts
TBritain OKs Pfizer vaccine and will begin shots within days twincities.com
Moscow , Russia , China , Belgium , Canada
European panel OKs Pfizer shot for youths 12-15 nwaonline.com
Okinawa Prefecture , Fukuoka Prefecture , Hokkaido Prefecture , Osaka Prefecture , Tokyo Prefecture
Pfizer wants approval for promising COVID-19 pill reviewjournal.com
United Kingdom , United States , Pill unter dem Bache
EU regulator OKs plan to increase monkeypox vaccine supplies Merced Sun-Star
Africa , Europe , Michigan , Miami Beach
Pfizer asks US officials to OK promising COVID-19 pill Star Telegram
Washington , United Kingdom , United States